BioSpace News Archive

Drug Development

Themis Bioscience Publishes Compelling Phase 2 Results for Lead Vaccine Candidate against Chikungunya Fever in The Lancet

MV-CHIK met the primary endpoint, eliciting a potent immune response as measured by induction of neutralizing antibodies against Chikungunya, in all treatment groups

November 5, 2018
·
4 min read
Drug Development

Ascletis to Present Phase II / III Clinical Study for Its All-oral HCV Treatment at the 69th Annual meeting of AASLD

Ascletis Pharma Inc. announces today that a phase II / III clinical study of its all-oral HCV treatment (RDV/DNV Regimen) has been selected by AASLD’s Scientific Program Committee as a Poster Presentation.

November 5, 2018
·
2 min read
BioForest

Merck Halts Supply of Lifesaving Vaccine for African Kids to Seek Greater Profits in China, US, Says AHF

AHF condemns Merck for cutting off lifesaving vaccine for children dying from diarrhea in Africa while it also announces plans to expand distribution—and far more lucrative sales—in China

November 5, 2018
·
3 min read
Biotech Beach

NantKwest Announces Multiple Presentations at the 2018 Society for Immunotherapy of Cancer Conference

Update on Off-The-Shelf CD16 Targeted NK Cell (haNK) and NANT Cancer Vaccine Program Including Interim Data Analysis for Pancreatic Cancer, Triple Negative Breast Cancer & Head and Neck Cancer Trials

November 5, 2018
·
3 min read
Deals

Natcore Technology Signs MOU to Merge With Innovative Medical Technology Company

Natcore Technology Inc. (TSX-V: NXT; OTCQB: NTCXF), a technology research company, has advanced an MOU that would result in a merger with a privately held firm and its subsidiaries that would become wholly owned subsidiaries of Natcore.

November 5, 2018
·
5 min read
Business

Stanford Children’s Health names Paul King President and CEO

Stanford Children’s Health announced Friday that its board of directors has appointed Paul King as president and CEO of Lucile Packard Children’s Hospital Stanford and Stanford Children’s Health, effective in early 2019.

November 5, 2018
·
4 min read
Policy

Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA’s effort to make more robust use of mandatory recall authority to quickly remove unsafe foods from the market

Hazardous foods or potentially contaminated products can expose Americans to foodborne illness that can sometimes be life threatening.

November 5, 2018
·
5 min read
Biotech Bay

eHealth, Inc. to Present at Upcoming Investor Conferences

eHealth, Inc. (NASDAQ: EHTH), a leading private online health insurance exchange, announced today that its senior management will deliver presentations at the following upcoming investor conferences:

November 5, 2018
·
1 min read
Biotage AB (publ) Publishes New Financial Goals

Biotage has two financial goals in its business, an organic sales growth goal of 8 percent and a profitability goal on EBIT- level of 15 percent.

November 5, 2018
·
1 min read
Pharm Country

3BP, Inc. Announces Patent Issued for Package Damage Indication

The newly issued patent for Damage-Indicating PackagingTM allows 3BP, Inc. (“3BP”) to move forward with more extensive research and development and further expand its smart packaging product line.

November 5, 2018
·
3 min read